Emma Muñoz-Sáez

Dr. Emma Muñoz-Sáez

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2013 in Environmental Toxicology and Pharmacology
Verified
Journal Article
Closed access
EMEstefanía de Munck
Estefanía de Munck
EMEmma Muñoz-Sáez
Emma Muñoz-Sáez
BMBegoña G. Miguel
Begoña G. Miguel
MSM. Teresa Solas
M. Teresa Solas
IOIrene Ojeda
Irene Ojeda
RARosa Mª Arahuetes
Rosa Mª Arahuetes

9 July 2021 in Developmental Dynamics
Verified
Journal Article
Open access
PDF file
NMNatalia Moracho
Natalia Moracho
ALAna I. R. Learte
Ana I. R. Learte
EMEmma Muñoz-Sáez
Emma Muñoz-Sáez
MMMiguel A. Marchena
Miguel A. Marchena
MCMaría A. Cid
María A. Cid
CBCristina Sánchez-Camacho Blázquez
Cristina Sánchez-Camacho Blázquez
Membrane‐type matrix metalloproteinases (MT‐MMPs) are cell membrane‐tethered proteinases that belong to the family of the MMPs. Apart from their roles in degradation of the extracellular milieu, MT‐MMPs are able to activate through proteolytic processing at the cell surface distinct molecules such as receptors, growth factors, cytokines, adhesion molecules, and other pericellular proteins. Although most of the information regarding these enzymes comes from cancer studies, our current knowledge about their contribution in distinct developmental processes occurring in the embryo is limited. In this review, we want to summarize the involvement of MT‐MMPs in distinct processes during embryonic morphogenesis, including cell migration and proliferation, epithelial‐mesenchymal transition, cell polarity and branching, axon growth and navigation, synapse formation, and angiogenesis. We also considered information about MT‐MMP functions from studies assessed in pathological conditions and compared these data with those relevant for embryonic development.

1 May 2015 in Environmental Toxicology and Pharmacology
Verified
Journal Article
Closed access
EMEstefanía de Munck
Estefanía de Munck
EMEmma Muñoz-Sáez
Emma Muñoz-Sáez
BMBegoña G. Miguel
Begoña G. Miguel
MSMª Teresa Solas
Mª Teresa Solas
Ana MartinezAna Martinez
Ana Martinez
RARosa Mª Arahuetes
Rosa Mª Arahuetes

1 January 2013 in The Journal of Toxicological Sciences
Verified
Journal Article
Closed access
EMEmma Muñoz-Sáez
Emma Muñoz-Sáez
EMEstefanía de Munck
Estefanía de Munck
RARosa M. Arahuetes
Rosa M. Arahuetes
MSM. Teresa Solas
M. Teresa Solas
AMAna M. Martínez
Ana M. Martínez
BMBegoña G. Miguel
Begoña G. Miguel
β-N-methylamino-L-alanine (L-BMAA) is a neurotoxic amino acid produced by most cyanobacteria, which are extensively distributed in different environments all over the world. L-BMAA has been linked to a variety of neurodegenerative diseases. This work aims to analyze the toxicological action of L-BMAA related to alterations observed in different neurodegenerative illness as Alzheimer disease and amyotrophic lateral sclerosis. Our results demonstrate that neuroblastoma cells treated with L-BMAA show an increase in glycogen synthase kinase 3 β (GSk3β) and induce accumulation of TAR DNA-binding protein 43 (TDP-43) truncated forms (C-terminal fragments), phosphorylated and high molecular weight forms of TDP-43, that appears frequently in some neurodegenerative diseases.

1 March 2013 in Environmental Toxicology and Pharmacology
Verified
Journal Article
Closed access
EMEstefanía de Munck
Estefanía de Munck
EMEmma Muñoz-Sáez
Emma Muñoz-Sáez
MAMaría Teresa Antonio
María Teresa Antonio
JPJavier Pineda
Javier Pineda
AHAmparo Herrera
Amparo Herrera
RARosa María Arahuetes
Rosa María Arahuetes

1 May 2015 in NeuroToxicology
Verified
Journal Article
Closed access
EMEmma Muñoz-Sáez
Emma Muñoz-Sáez
EGEstefanía de Munck García
Estefanía de Munck García
RPRosa Mª Arahuetes Portero
Rosa Mª Arahuetes Portero
Ana MartinezAna Martinez
Ana Martinez
MAMª Teresa Solas Alados
Mª Teresa Solas Alados
BMBegoña Gómez Miguel
Begoña Gómez Miguel